Analyst firms · Guggenheim · INCY

Guggenheim INCY price target and rating history

Incyte Corp. (INCY) · Health Care

Guggenheim rates Incyte Corp. (INCY) Buy with a $125 price target, as of its latest action on Nov 3, 2025. It has published 4 rating actions on INCY since August 2022, including 2 upgrades and 2 downgrades. Across 9 firms with a INCY price target in the last 12 months, the median target is $119.

Current rating
Buy
Price target
$125
Median target, all firms
$119
Actions on INCY
4

Guggenheim price target on INCY

$125$106$86202420252026
Guggenheim price target on INCY, each point a stated target, December 2023 to November 2025.

Every Guggenheim rating on INCY

How other firms rate INCY

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
OppenheimerOutperform$144Oct 30, 2026
Morgan StanleyEqual-Weight$119Oct 20, 2026
Canaccord GenuityBuy$152Aug 20, 2026
BMO Capital MarketsMarket Perform$94Jun 22, 2026
BernsteinMkt Perform$99May 22, 2026
JefferiesHold$94Mar 16, 2026
H.C. WainwrightBuy$135Feb 5, 2026
Wells FargoEqual Weight$107Jan 20, 2026
MizuhoOutperform$121Dec 8, 2025

Questions about Guggenheim and INCY

What is Guggenheim's price target for INCY?
Guggenheim's latest stated price target for Incyte Corp. (INCY) is $125, from its action on Nov 3, 2025.
What is Guggenheim's rating on INCY?
Guggenheim rates INCY Buy, a bullish rating, as of Nov 3, 2025.
When did Guggenheim last change its view on INCY?
On Nov 3, 2025, Guggenheim upgrades to Buy from Neutral, price target $125.
How does Guggenheim's INCY target compare with other analysts?
Across 9 firms with a INCY price target in the last 12 months, the median target is $119.

More INCY rating histories

All Guggenheim ratingsINCY news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.